Your browser doesn't support javascript.
loading
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall, Jennifer; Buckley, Rebecca H; Puck, Jennifer; Fleisher, Thomas A; Gennery, Andrew R; Haddad, Elie; Neven, Benedicte; Slatter, Mary; Roderick, Skinner; Baker, K Scott; Dietz, Andrew C; Duncan, Christine; Griffith, Linda M; Notarangelo, Luigi; Pulsipher, Michael A; Cowan, Morton J.
Afiliação
  • Heimall J; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: heimallj@email.chop.edu.
  • Buckley RH; Departments of Pediatrics and Immunology, Duke University Medical Center, Durham, North Carolina.
  • Puck J; Department of Pediatrics, Allergy, Immunology, and Blood and Marrow Transplant Division, University of California San Francisco, San Francisco California, California.
  • Fleisher TA; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland.
  • Gennery AR; Department of Paediatric Immunology, Newcastle upon Tyne, United Kingdom Institute of Cellular Medicine, Newcastle upon Tyne University, Newcastle upon Tyne, United Kingdom.
  • Haddad E; Department of Pediatrics, Department of Microbiology, Infection and Immunology, University of Montreal, CHU Sainte-Justine, Montreal, Quebec, Canada.
  • Neven B; Department of Immunology, Bone Marrow Transplantation, Hospital Necker Enfants Malades, Paris, France.
  • Slatter M; Department of Paediatric Immunology, Newcastle upon Tyne, United Kingdom Institute of Cellular Medicine, Newcastle upon Tyne University, Newcastle upon Tyne, United Kingdom.
  • Roderick S; Great North Children's Hospital and Northern Institute of Cancer Research, Newcastle upon Tyne, United Kingdom.
  • Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Dietz AC; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California.
  • Duncan C; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
  • Griffith LM; Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
  • Notarangelo L; Laboratory of Host Defenses, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
  • Pulsipher MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
  • Cowan MJ; Department of Pediatrics, Allergy, Immunology, and Blood and Marrow Transplant Division, University of California San Francisco, San Francisco California, California.
Biol Blood Marrow Transplant ; 23(8): 1229-1240, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28479164

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article